Delivery Order SPE2DB22D3301-SPE2DB26FX3KH
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,013.55 for Naropin 0.5% (150 mg/30 mL vial) with an ultimate completion date of October 16, 2025. This firm fixed price, non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.71 firm fixed-price delivery order covers the supply of NAROPIN 0.2% 400 MG/200 ML BTL 200ML, a specialty pharmaceutical product, with a performance period ending on August 30, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEKV1, valued at $2,638.47, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This firm fixed price delivery order is for the supply of 4564230198 NAROPIN 0.5% 150 MG/30 ML VIAL 30ML to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp, which has a potential value of...
- This federal contract award is for the delivery of NAROPIN 0.2% 400 MG/200 ML BTL 200ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract, valued at $5,214.94, was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a delivery order contract with a firm fixed price pricing type. The...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 150 mg/20 ml vials of the pharmaceutical product NAROPIN 0.75% in support of military treatment programs and facilities. The order has a potential value of $1,580.06 and a completion date of January 24, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Ropivacaine 0.2% (200 mg/100 mL) in 100 mL units, with a ceiling value of $1,419.66 and a firm fixed price structure. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was issued with no set-aside...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a firm fixed price ceiling value of $1,270.82. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.23 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials on April 29, 2025. This competitively awarded, firm fixed-price delivery order is classified as a non-set-aside contract and carries an ultimate completion date of April 30, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...